Effect of liraglutide on cardiovascular outcomes in patients with or without prior heart failure history in LEADER

被引：0
|
作者：
Saevereid, H. A. [1 ]
Husain, M. [2 ]
Bain, S. C. [3 ]
Mann, J. F. E. [4 ]
Nauck, M. A. [5 ]
Poulter, N. [6 ]
Goldman, B. [1 ]
Thomsen, A. B. [1 ]
Marso, S. [7 ]
机构：
[1] Novo Nordisk AS, Soborg, Denmark
[2] Toronto Gen Hosp, Res Inst, Ted Rogers Ctr Heart Res, Toronto, ON, Canada
[3] Swansea Univ, Inst Life Sci, Swansea, W Glam, Wales
[4] Friedrich Alexander Univ Erlangen, Erlangen, Germany
[5] Ruhr Univ Bochum, St Josef Hosp, Diabet Ctr Bochum Hattingen, Bochum, Germany
[6] Imperial Coll London, London, England
[7] HCA Midwest Hlth Heart & Vasc Inst, Kansas City, MO USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1155
引用
收藏
页码：S564 / S565
页数：2
相关论文
共 50 条
  • [1] Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure
    Marso, Steven P.
    Baeres, Florian M. M.
    Bain, Stephen C.
    Goldman, Bryan
    Husain, Mansoor
    Nauck, Michael A.
    Poulter, Neil R.
    Pratley, Richard E.
    Thomsen, Anne Bloch
    Buse, John B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (10) : 1128 - 1141
  • [2] Effect of liraglutide on cardiovascular outcomes in elderly patients in the LEADER trial
    Gilbert, M. P.
    Bain, S. C.
    Franek, E.
    Jodar-Gimeno, E.
    Nauck, M. A.
    Pratley, R. E.
    Rea, R.
    Saraiva, J.
    Rasmussen, S.
    Tornoe, K.
    von Scholten, B.
    Buse, J.
    DIABETOLOGIA, 2018, 61 : S368 - S369
  • [3] EFFECT OF LIRAGLUTIDE ON CARDIOVASCULAR OUTCOMES IN ELDERLY PATIENTS IN THE LEADER TRIAL
    Gilbert, Matthew
    Bain, Stephen
    Franek, Edward
    Jodar-Gimeno, Esteban
    Nauck, Michael
    Pratley, Richard
    Rea, Rosangela
    Saraiva, Jose
    Rasmussen, Soren
    Tornoe, Karen
    von Scholten, Bernt Johan
    Buse, John B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1718 - 1718
  • [4] NO INCREASED RISK OF HEART FAILURE HOSPITALIZATION OR MAJOR CARDIOVASCULAR EVENTS OBSERVED WITH LIRAGLUTIDE IN PATIENTS WITH OR WITHOUT A HISTORY OF NEW YORK HEART ASSOCIATION CLASS II-III HEART FAILURE: RESULTS FROM THE LEADER TRIAL
    Husain, Mansoor
    Bain, Stephen C.
    Mann, Johannes F. E.
    Nauck, Michael A.
    Poulter, Neil
    Baeres, Florian M. M.
    Goldman, Bryan
    Thomsen, Anne Bloch
    Marso, Steven P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 673 - 673
  • [5] Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
    Petrie, Mark C.
    Verma, Subodh
    Docherty, Kieran F.
    Inzucchi, Silvio E.
    Anand, Inder
    Belohlavek, Jan
    Boehm, Michael
    Chiang, Chern-En
    Chopra, Vijay K.
    de Boer, Rudolf A.
    Desai, Akshay S.
    Diez, Mirta
    Drozdz, Jaroslaw
    Dukat, Andre
    Ge, Junbo
    Howlett, Jonathan
    Katova, Tzvetana
    Kitakaze, Masafumi
    Ljungman, Charlotta E. A.
    Merkely, Bela
    Nicolau, Jose C.
    O'Meara, Eileen
    Vinh, Pham Nguyen
    Schou, Morten
    Tereshchenko, Sergey
    Kober, Lars
    Kosiborod, Mikhail N.
    Langkilde, Anna Maria
    Martinez, Felipe A.
    Ponikowski, Piotr
    Sabatine, Marc S.
    Sjostrand, Mikaela
    Solomon, Scott D.
    Johanson, Per
    Greasley, Peter J.
    Boulton, David
    Bengtsson, Olof
    Jhund, Pardeep S.
    McMurray, John J. V.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (14): : 1353 - 1368
  • [6] Effect of vericiguat on cardiovascular outcomes in patients with heart failure with and without diabetes: Insights from the VICTORIA trial
    Khan, S.
    Butler, J.
    Young, R.
    Lewis, B. S.
    Escobedo, J.
    Refsgaard, J.
    Reyes, E.
    Roessig, L.
    Blaustein, R. O.
    Lam, C. S. P.
    Voors, A. A.
    Ponikowski, P.
    Anstrom, K. J.
    Armstrong, P.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [7] Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke Post Hoc Analysis From the LEADER Trial
    Verma, Subodh
    Poulter, Neil R.
    Bhatt, Deepak L.
    Bain, Stephen C.
    Buse, John B.
    Leiter, Lawrence A.
    Nauck, Michael A.
    Pratley, Richard E.
    Zinman, Bernard
    Orsted, David D.
    Fries, Tea Monk
    Rasmussen, Soren
    Marso, Steven P.
    CIRCULATION, 2018, 138 (25) : 2884 - 2894
  • [8] Comparison of Outcomes After Hospitalization Among Heart Failure Patients With and Without History of Heart Transplantation
    Basnet, S.
    Dhital, R.
    Tharu, B.
    Poudel, D. R.
    Donato, A.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3720 - 3722
  • [9] The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients
    Nielsen, Roni
    Jorsal, A.
    Tougaard, R. S.
    Rasmussen, J.
    Schou, M.
    Videbaek, L.
    Gustafsson, I.
    Flyvbjerg, A.
    Wiggers, H.
    Tarnow, L.
    Kistorp, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 21 - 22
  • [10] Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
    Crowley, Matthew J.
    McGuire, Darren K.
    Alexopoulos, Anastasia-Stefania
    Jensen, Thomas Jon
    Rasmussen, Soren
    Saevereid, Hans A.
    Verma, Subodh
    Buse, John B.
    DIABETES CARE, 2020, 43 (09) : E108 - E110
12345